| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.0M | — | +22.1% |
| Cost of Revenue | $6.2M | — | +29.8% |
| R&D Expense | $540K | — | -86.3% |
| SG&A Expense | $15.9M | — | -38.1% |
| Operating Income | -$7.7M | — | +65.3% |
| Interest Expense | $3.4M | — | +20.1% |
| Pre-tax Income | $142.3M | — | +676.3% |
| Income Tax | $5.1M | — | — |
| Net Income | $110.4M | — | +1142.8% |
| EPS (Basic) | $3.44 | — | +816.7% |
| EPS (Diluted) | $2.82 | — | +687.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $255.8M | +222.3% | +180.1% |
| Accounts Receivable | $25.0M | -16.1% | +38.7% |
| Inventory | $9.3M | -3.4% | -25.6% |
| Current Assets | $295.5M | +138.6% | +132.8% |
| Total Assets | $356.9M | +92.3% | +100.4% |
| Current Liabilities | $103.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $203.9M | — | +1142.0% |
| Investing Cash Flow | $0 | — | -100.0% |
| Financing Cash Flow | -$27.4M | — | -152.5% |
| +40.3% |
| Long-term Debt | $37.5M | -28.5% | -33.5% |
| Total Liabilities | $154.5M | +25.2% | +6.1% |
| Stockholders' Equity | $162.2M | +225.2% | +629.0% |